Zerovalent bismuth nanoparticles inhibit Streptococcus mutans growth and formation of biofilm

International Journal of Nanomedicine

Volumn 7, Issue , 2012, Pages 2109-2113

  Hernandez Delgadillo, Rene ^a   Velasco Arias, Donaji ^b   Diaz, David ^b   Arevalo Niño, Katiushka ^a   Garza Enriquez, Marianela ^a   De la Garza Ramos, Myriam A ^a   Cabral Romero, Claudio ^a  

^a UNIVERSIDAD AUTÓNOMA DE NUEVO LEÓN   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Antimicrobial agent; Biofilm; Streptococcus mutans; Zerovalent bismuth nanoparticles

Indexed keywords

ANTIINFECTIVE AGENT; CHLORHEXIDINE; UNCLASSIFIED DRUG; ZEROVALENT BISMUTH NANOPARTICLE; BISMUTH; METAL NANOPARTICLE;

ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIAL MEMBRANE; BIOFILM; CONCENTRATION RESPONSE; CONTROLLED STUDY; GROWTH INHIBITION; MEMBRANE FORMATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; STREPTOCOCCUS MUTANS; ANTIBIOTIC RESISTANCE; CHEMISTRY; DRUG EFFECT; GROWTH, DEVELOPMENT AND AGING; HUMAN; IN VITRO STUDY; MICROBIOLOGICAL EXAMINATION; NANOMEDICINE; PHYSIOLOGY; TRANSMISSION ELECTRON MICROSCOPY; ULTRASTRUCTURE;

STREPTOCOCCUS MUTANS;

ANTI-INFECTIVE AGENTS; BIOFILMS; BISMUTH; DRUG RESISTANCE, BACTERIAL; HUMANS; METAL NANOPARTICLES; MICROBIAL SENSITIVITY TESTS; MICROSCOPY, ELECTRON, TRANSMISSION; NANOMEDICINE; STREPTOCOCCUS MUTANS;

EID: 84863832883     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S29854     Document Type: Article

References (23)

1. Costerton JW. Overview of microbial biofilms. J Ind Microbiol. 1995;15(3):137-140.
2. Costerton JW. Introduction to biof ilm. Int J Antimicrob Agents. 1999;11(3-4):217-221.
3. Jenkinson HF. Adherence and accumulation of oral streptococci. Trends Microbiol. 1994;2(6):209-212.
4. Guntheroth WG. How important are dental procedures as a cause of infective endocarditis? Am J Cardiol. 1984;54(7):797-801.
5. Falagas ME, Fragoulis KN, Karydis I. A comparative study on the cost of new antibiotics and drugs of other therapeutic categories. PloS One. 2006;1:e11.
6. Kirk RE, Othmer DF. Encyclopedia of Chemical Technology. 3rd ed. New York, NY: Chichester, Wiley; 1980.
7. Figueroa-Quintanilla D, Salazar-Lindo E, Sack RB, et al. A controlled trial of bismuth subsalicylate in infants with acute watery diarrheal disease. N Engl J Med. 1993;328(23):1653-1658.
8. Zhang Z, Yu K, Bai D, Zhu Z. Synthesis and electrochemical sensing toward heavy metals of bunch-like bismuth nanostructures. Nanoscale Res Lett. 2009;5(2):398-402.
9. Chen R, So MH, Yang J, Deng F, Che CM, Sun H. Fabrication of bismuth subcarbonate nanotube arrays from bismuth citrate. Chem Commun (Camb). 2006;21:2265-2267.
10. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65(1-2):55-63.
11. Liu Y, Peterson DA, Kimura H, Schubert D. Mechanism of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction. J Neurochem. 1997;69(2):581-593.
12. Yue H, Eastman PS, Wang BB, et al. An evaluation of the performance of cDNA microarrays for detecting changes in global mRNA expression. Nucleic Acids Res. 2001;29(8):E41.
13. Frey T. Nucleic acid dyes for detection of apoptosis in live cells. Cytometry. 1995;21(3):265-274.
14. Andrews JM. Determination of minimum inhibitory concentrations. J Antimicrob Chemother. 2001;48 Suppl 1:5-16.
15. Colvin VL. The potential environmental impact of engineered nanomaterials. Nat Biotechnol. 2003;21(10):1166-1170.
16. Sondi I, Salopek-Sondi B. Silver nanoparticles as antimicrobial agent: a case study on E. coli as a model for Gram-negative bacteria. J Colloid Interface Sci. 2004;275(1):177-182.
17. Ren G, Hu D, Cheng EW, Vargas-Reus MA, Reip P, Allaker RP. Characterisation of copper oxide nanoparticles for antimicrobial applications. Int J Antimicrob Agents. 2009;33(6):587-590.
18. Tran PA, Webster TJ. Selenium nanoparticles inhibit Staphylococcus aureus growth. Int J Nanomedicine. 2011;6:1553-1558.
19. Kim JS, Kuk E, Yu KN, et al. Antimicrobial effects of silver nanoparticles. Nanomedicine. 2007;3(1):95-101.
20. Feng QL, Wu J, Chen GQ, Cui FZ, Kim TN, Kim JO. A mechanistic study of the antibacterial effect of silver ions on Escherichia coli and Staphylococcus aureus. J Biomed Mater Res. 2000;52(4):662-668.
21. Yamanaka M, Hara K, Kudo J. Bactericidal actions of a silver ion solution on Escherichia coli, studied by energy-filtering transmission electron microscopy and proteomic analysis. Appl Environ Microbiol. 2005;71(11):7589-7593.
22. Bragg PD, Rainnie DJ. The effect of silver ions on the respiratory chain of Escherichia coli. Can J Microbiol. 1974;20(6):883-889.
23. Sambhy V, MacBride MM, Peterson BR, Sen A. Silver bromide nanoparticle/polymer composites: dual action tunable antimicrobial materials. J Am Chem Soc. 2006;128(30):9798-9808.